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Abstract
Background: Deficiency in Vitamin D3 (cholecalciferol) may predispose to some malignancies, including gonadal
tumors and in experimental models vitamin D3 has been proven to inhibit the growth of cancer cells. To learn
more about the potential role of vitamin D3 in cancerogenesis, we evaluated the expression and functionality
of the vitamin D receptor (VDR) and its role in metastasis of ovarian cancer cells and of murine and human
teratocarcinoma cell lines.
Methods: In our studies we employed murine embrynic stem cells (ESD3), murine (P19) and human (NTERA-2)
teratocarcimona cells lines, human ovarian cancer cells (A2780) as well as purified murine and human purified
very small embryonic like stem cells (VSELs). We evaluated expression of Vitamin D3 receptor (VDR) in these cells
as well as effect of vitamin D3 exposure on cell proliferation and migration.
Results: We here provide also more evidence for the role of vitamin D3 in germline-derived malignancies, and
this evidence supports the proposal that vitamin D3 treatment inhibits growth and metastatic potential of several
germline-derived malignancies. We also found that the ESD3 murine immortalized embryonic stem cell line and
normal, pluripotent, germline-marker-positive very small embryonic-like stem cells (VSELs) isolated from adult
tissues are stimulated by vitamin D3, which suggests that vitamin D3 affects the earliest stages of embryogenesis.
Conclusions: We found that however all normal and malignant germ-line derived cells express functional VDR,
Vitamin D3 differently affects their proliferation and migration. We postulate that while Vitamin D3 as anticancer
drug inhibits proliferation of malignant cells, it may protect normal stem cells that play an important role in
development and tissue/organ regeneration.
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Background
Germline cell tumors are derived from cells endowed
with early developmental potential. These tumors are
located mostly in ovaries and testes, but they may also
develop in the pelvis, in the mediastinal area, and intra-
cranially [1]. It has been proposed that these extra-
gonadal tumors arise from mutated primordial germ
cells (PGCs) that migrate during embryogenesis and
stray from their main route through the embryo proper
to the genital ridges [2]. This theory of origin explains
the most common locations of germline tumors along
the PGC migratory route, beginning from the extraem-
bryonic mesoderm, moving through the primitive streak,
and ending in the developing gonads. The most not-
able of this type of extra-gonadal germline tumor is
the sacrococcygeal teratoma, the single most common
tumor diagnosed in babies at birth [3, 4]. This site
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marks the anatomical area where PGCs, after leaving the
extraembryonic mesoderm, enter the embryo proper.
It has also been proposed that early in embryogenesis,
stem cells expressing several germline characteristics are
deposited in developing organs [5, 6]. These stem cells
deposited at somatic sites may serve as a backup popula-
tion for tissue-committed stem cells. Interestingly, very
small embryonic-like stem cells (VSELs), which express
several markers of migratory PGCs, have been identified
in several organs, including bone marrow, ovaries, and
testes [6, 7]. Moreover, cells with germline potential have
been identified not only in gonads but also in bone
marrow (BM), skin, esophagus, and even breast milk
[8–10]. Similarly, exposure of BM mononuclear cells
(MNCs) to chemical carcinogens revealed germline
potential implicit in BM-adherent cells [11].
These examples are mostly in line with the so-called
“embryonic rest hypothesis of cancer development”. Dur-
ing the 19th and early 20th centuries, it was proposed by
Recamier (1829), Remak (1854), and Virchow (1858) and
later elaborated by Durante (1874) and Cohnheim (1875)
that cancer may originate in populations of cells that are
left in a dormant state in developing organs during em-
bryogenesis [12–16]. It is possible that certain developing
tumors classified as germline tumors originate in such
cells (stray migrating PGCs or VSELs). On the other hand,
since several malignancies express so-called cancer testis
antigens and respond to stimulation by pituitary and
gonadal sex hormones [17, 18], we cannot exclude the
possibility that other types of malignancies also originate
in cells related to the germline [19, 20].
Vitamin D3 is a prohormone that prevents the devel-
opment of tumors [21–25]. Specifically, a deficiency of
this vitamin is implied in the origin of several malignan-
cies, as it has been demonstrated in several experimental
models that the growth of many tumor cell lines, includ-
ing lung, breast, testicular, and ovarian cancer, as well as
leukemia and lymphoma are inhibited by exposure to
vitamin D3 [26, 27].
To better address the role of vitamin D3 in germline-
derived tumors, we investigated the expression and po-
tential role of the vitamin D3 receptor (VDR) in ovarian
cancer and teratocarcinoma cells. We also evaluated the
expression of the VDR in murine and human VSELs.
Thus, our results provide more evidence for the poten-
tial role of vitamin D3 in germline-derived malignancies
and support the proposal that vitamin D3 treatment
inhibits the growth and metastatic potential of germline-
derived malignancies [21, 22, 24, 25, 28]. Since we also
found VDR expression on ESD3 murine embryonic stem
cells, this observation supports the role of the VDR at
the earliest stages of embryogenesis. Finally, we observed
differences in the effect of vitamin D3 in malignant
versus normal germline-related cells, which supports its




Both human (NTERA-2 teratocarcinoma, A2780 ovarian
cancer) and murine (P19 embryonal teratocarcinoma)
germline-derived immortalized cell lines were employed
in our studies. All cell lines were purchased from American
Type Culture Collection (ATCC; Manassas, VA, USA).
NTERA-2 cells were cultured in Dulbecco’s modified Eagle
medium (DMEM; GE Healthcare) with heat-inactivated
10 % fetal bovine serum (FBS; Seradigm). A2780 ovarian
cancer cells were maintained in Roswell Park Memorial
Institute (RPMI) medium 1640 containing L-glutamine
(GE Healthcare) and 10 % heat-inactivated FBS. P19
embryonal carcinoma cells were cultured in minimum
essential medium (MEM)-α (GE Healthcare) supple-
mented with ribonucleosides, deoxyribonucleosides, 2.5
FBS, and 7.5 % bovine calf serum. To all media, penicillin
(100 units/mL; Corning) and streptomycin (10 μg/mL;
Corning) were added. All cells were cultured in a humidi-
fied atmosphere of 5 % CO2 at 37 °C, with exchange of
medium every 48 h.
Cultivation of the ESD3 murine embryonic stem cell line
The ESD3 cell line was purchased from ATCC and cul-
tured in DMEM (GE Healthcare) with 4 mM L-glutam-
ine, 1.5 g/L sodium bicarbonate, and 4.5 g/L glucose and
supplemented with 0.1 mM 2-mercaptoethanol (Sigma-
Aldrich), heat-inactivated 15 % FBS, and murine mature
leukemia inhibitory factor (LIF, 5 ng/mL; Santa Cruz
Biotechnology). Cells were maintained in a humidified
atmosphere of 5 % CO2 at 37 °C, and the medium
was exchanged every 48 h.
Isolation of murine hematopoietic stem cells (HSCs) and
very small embryonic-like stem cells (VSELs) from bone
marrow
Bone marrow mononuclear cells (BMMNCs) were ob-
tained from total BM cells flushed from femurs and
tibias, lysed in BD lysing buffer (BD Biosciences, San
Jose, CA) for 10 min at room temperature, washed
twice in RPMI 1640 medium containing L-glutamine
(Corning), and supplemented with 2 % heat-inactivated
FBS. Next, MNCs were stained with the following anti-
bodies: anti-CD45R/B220 (phycoerythrin [PE], clone
RA-6B2), anti-Gr-1 (PE, clone RB6-8 C5), anti-T cell
receptor αβ (PE, clone H57-5970), anti-T cell receptor
ɤδ (PE, clone GL3), anti-CD11b (PE, clone M1/70),
anti-Ter119 (PE, clone TER-119), anti-CD45 (allophy-
cocyanin [APC]–Cy7, clone 30-F11), and anti-Ly-6A/E
(also known as Sca-1, PE–Cy5 or Alexa Fluor 647,
clone E13–161.7) for 30 min on ice. Cells were washed
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and resuspended in RPMI medium with 2 % FBS.
Hematopoietic stem cells (HSCs; Sca-1+Lin−CD45+)
and very small embryonic-like stem cells (VSELs; Sca-1+
Lin−CD45−) were purified from MNCs using a multi-
parameter Moflo XDP cell sorter (Beckman Coulter) as
described [29].
Isolation of human UCB-derived HSPCs and VSELs
Clinical-grade human umbilical cord blood (hUCB) re-
search units obtained from Cleveland Cord Blood Center
were used for isolation of hUCB-HSPCs and hUCB-
VSELs as described in detail in our previous studies [30].
In brief, using a cocktail of biotin-conjugated monoclo-
nal antibodies and anti-biotin monoclonal antibodies
conjugated to paramagnetic microbeads (Lineage Cell
Depletion kit, Miltenyi Biotec), magnetic labeling of
retrieved total nucleated cells was performed, and the
lineage-negative (Lin−) cells were isolated by depletion
of mature hematopoietic cells expressing a panel of
lineage antigens using an autoMACS separator (Miltenyi
Biotec). Afterwards, the Lin− population were stained
with the following antibodies: anti-CD45 (PE or V450,
clone HI30) and anti-CD34 (APC or PE, clone 581).
After washing, the fluorochrome-labelled cells were resus-
pended and sorted to obtain populations enriched in HSCs
(Lin−/CD45+/CD34+) and VSELs (Lin−/CD45−/CD34+).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted and purified from teratocar-
cinomas and ESD3 cells using the RNeasy Mini kit
(Qiagen Inc.) after treatment with DNase I (Qiagen
Inc.) on a column. For VSELs and HSCs, total RNA
was extracted using Trizol Reagent (Ambion; Austin,
TX, USA) as described earlier [31]. The purified mRNA
was afterwards reverse-transcribed into cDNA using Taq-
man Reverse Transcription Reagents (Applied Biosys-
tems). Amplification of synthesized cDNA fragments was
carried out using Amplitaq Gold polymerase (Applied
Biosystems). The PCR conditions were: 1 cycle of 8 min at
95 °C; 2 cycles of 2 min at 95 °C, 1 min at 60 °C, and
1 min at 72 °C; 40 cycles of 30 s at 95 °C, 1 min at 60 °C,
and 1 min at 72 °C; and 1 cycle of 10 min at 72 °C. Semi-
nested PCR was performed only to evaluate expression of
the VDR in sorted VSELs. The human and murine
sequence-specific primers used for VDR amplification are
listed in Additional file 1: Figure S1. Samples with-
out template controls and reverse transcriptase were
used in each run. All primers were designed using
the NCBI/Primer-Blast program, as at least one pri-
mer included an exon–intron boundary. Afterwards,
all PCR products were analyzed by 2 % agarose gel
electrophoresis.
Reverse transcription quantitative PCR (RT-qPCR)
RT-qPCR experiments were performed to detect and
quantify relative levels of VDR mRNA in both human
and murine germline-derived immortalized cell lines. The
purified RNA was reverse-transcribed with MultiScribe
Reverse Transcriptase, oligo(dT), and a random hexamer
primer mix (all from Applied Biosystems Life Technolo-
gies, CA, USA). Quantitative evaluation of the target gene
was then performed by using an ABI Prism 7500 sequence
detection system (Applied Biosystems Life Technologies)
with Power SYBR-green PCR Master Mix reagent and
specific primers (Additional file 1: Figure S1). The PCR
cycling conditions were 95 °C (15 s), 40 cycles at 95 °C
(15 s), and 60 °C (1 min). According to melting point
analysis, only one PCR product was amplified under these
conditions. The relative quantity of a target gene, normal-
ized to the β2-microglobulin gene as the endogenous
control and relative to a calibrator, was expressed as
2–ΔΔCt (fold difference), where Ct is the threshold cycle,
ΔCt = (Ct of target genes) – (Ct of the endogenous control
gene, β2-microglobulin), and ΔΔCt = (ΔCt for target
gene in test sample) – (ΔCt for target gene in calibrator
sample).
In vivo BrdU labelling studies with murine HSCs and
VSELs
Normal 2-month-old C57Bl6 mice (male) were exposed
to a once-daily oral dosage of 8 × 102 IU 1,25-dihydroxy-
vitamin D3 in sesame oil for five consecutive days. Con-
trol mice received vehicle orally. Mice were also exposed
to BrdU (1 mg/animal/100 μL; BD Pharmingen) 2 days
before starting with 1,25-dihydroxyvitamin D3 treatment
and continued to the end of the experiment as described
[29]. Control mice were injected with saline and BrdU
solution. After 30 days, mice were sacrificed, and a single-
cell suspension was obtained and stained for the HSC and
VSEL phenotypes as described above. After cell-surface
staining of cells, the FITC BrdU Flow kit (BD Pharmin-
gen) staining protocol was employed, including fixation
and permeabilization, treatment with DNase to expose
incorporated BrdU, and finally staining with anti-BrdU–
FITC antibody. After washing, samples were analyzed
using a BD LSR II flow cytometer (BD Biosciences). At
least one million events were captured and analyzed using
BD FACSDiva software.
Transwell migration assay
All cell lines were rendered quiescent by incubation in
their basic medium supplemented with 0.5 % bovine
serum albumin (BSA, Sigma-Aldrich) at 37 °C and then
seeded at a density of 6 × 104 cells/100 μL/insert into the
upper chambers of Transwell inserts with 8-μm polycar-
bonate membranes (Corning). The lower Boyden cham-
bers received 1,25-dihydroxyvitamin D3 (Sigma-Aldrich)
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at both physiological (10−10 M) and supra-physiological
(10−9–10−7 M) concentrations in culture medium with
0.5 % BSA. The lower chambers containing 10 FBS and
0.5 % BSA (plus vehicle) in RPMI 1640 medium served as
a positive and negative control, respectively. After 24-h
stimulation at 37 °C, the upper chambers were carefully
removed, the cells that had not migrated were removed
with a cotton applicator swab from the upper side, and
the cells that had transmigrated to the lower side of the
membrane were fixed and stained with HEMA-3 reagent
(Protocol, Fisher Scientific, Pittsburgh, PA) and then
counted using an inverted microscope.
Adhesion of malignant cells to fibronectin
All cell lines were made quiescent for 3 h with 0.5 %
BSA in basic medium in a humidified atmosphere of 5 %
CO2 at 37 °C. Next, the cells were stimulated with 1,25-
dihydroxyvitamin D3 (at concentrations ranging from
10−10–10−7 M), SDF-1 (300 ng/mL), or 0.5 % BSA (plus
vehicle) in their respective basic culture media. Cells
were then added directly and allowed to adhere to the
fibronectin-coated wells (3000 cells/well) in 96-well
plates at 37 °C. The wells were first coated with 70 μL
of fibronectin (Sigma-Aldrich; 10 μg/mL) overnight at
4 °C and blocked before the experiment with BSA for
2 h at 37 °C. After a 5-min incubation at 37 °C, the
wells were vigorously washed three times with PBS, and
the remaining adherent cells were counted directly
under an inverted microscope.
Signal transduction studies
To evaluate the functionality of the vitamin D receptor
(VDR), quiescent cells were stimulated with 0.5 % BSA
medium (containing vehicle) or 1,25-dihydroxyvitamin
D3 (10−10, 10−9, 10−8, or 10−7 M) for 5 min or 12 h at
37 °C. The harvested cells were washed with PBS, lysed
with RIPA lysis buffer supplemented with protease and
phosphatase inhibitors (Santa Cruz Biotech) for 30 min
on ice, and centrifuged at 15,000 rpm at −4 °C for
15 min. The protein concentration was measured using
the Pierce BCA Protein Assay Kit (Pierce, Rockford, IL).
The adjusted extracted proteins (20 μg/each sample)
were then separated on a 4–12 % SDS-PAGE gel, and
the fractionated proteins were transferred to a PVDF
membrane (Bio-Rad). All membranes were blocked with
2.5 % BSA in Tris-buffered saline containing 0.1 %
Tween (TBST) for 1 h at room temperature. After
washing with TBST, phosphorylation of the intracellular
kinase p44⁄42 mitogen-activated protein kinase (p42/44
MAPK) and AKT was detected by incubating the
membranes with phosphospecific anti-p-p42/44 MAPK
(clone no. 9101, diluted 1:1000) and anti-p-AKT (Ser473;
clone no. 9271, diluted 1:1000) rabbit polyclonal anti-
bodies (Cell Signaling), respectively, overnight at 4 °C.
Horseradish peroxidase (HRP)-conjugated goat anti-
rabbit IgG was used as a secondary antibody (Santa
Cruz Biotech, 1:5000) and was incubated with the
PVDF membranes for 2 h at RT. To confirm equal pro-
tein loading in all lanes, blots were stripped using strip-
ping buffer (Thermo Scientific) and then reprobed with
appropriate anti-rabbit p42/44 MAPK (clone no. 9102)
and anti-rabbit AKT (clone no. 9272) monoclonal anti-
bodies (both from Cell Signaling). All membranes were
treated with an enhanced chemiluminescence (ECL)
reagent (Amersham Life Sciences) and subsequently
exposed to film (Hyperfilm, Amersham Life Sciences).
For band visualization, the automatic machine supplied
with fresh warm developer and fixer solutions was
used.
Cell proliferation
Cells were cultured in 96-well plates (Cell Star; Greiner
Bio-One) at an initial density of 3 × 103 cells/mL with
0.5 % BSA in DMEM (NTERA2), RPMI 1640 (A2780),
or αMEM (P19) medium in the presence or absence of
1,25-dihydroxyvitamin D3 (10−10 M, 10−9 M, 10−8 M, or
10−7 M). The medium containing 0.5 % BSA with vehicle
was used as a negative control, while full medium con-
taining 10 % FBS was treated as a positive control. The
cell number was calculated directly after cell seeding
(0 h) as well as at 24, 48, and 72 h after adding 1,25-
dihydroxyvitamin D3. At these time points, cells were
harvested from the wells after trypsinization and counted
using FACS.
Cell transplantation into immunodeficient mice
Prior to in vivo transplantation, human germline-derived
immortalized cells were pretreated ex vivo with 1,25-
dihydroxyvitamin D3 (10−9 M) or vehicle alone for 12 h.
The cells were then washed and transplanted (10 × 105 per
mouse) into severe combined immunodeficient (SCID)-
beige inbred mice (n = 3 per group), which were irradiated
with 750 cGy 24 h before transplantation. At 48 h post
transplantation, bone marrows, livers, and lungs were
collected, and the presence of metastasized cancer cells
(i.e., murine–human chimerism) was evaluated as de-
scribed [32]. Briefly, genomic DNA was purified from
organs using the QIAamp DNA Mini kit (Qiagen).
Next, detection of human α-satellite and murine β-
actin DNA levels was carried out using real-time PCR
and the ABI Prism Fast 7500 Sequence Detection Sys-
tem (Applied Biosystems). A 25-μL reaction mixture
containing 12.5 μL SYBR Green PCR Master Mix,
300 ng DNA template, and specific primers (5′-acc
actctgtgtccttcgttcg-3′ [sense] and 5′-actgcgctctcaaaag
gagtgt-3′ [antisense] primers for α-satellite DNA; 5′-ttc
aattccaacactgtcctgtct-3′ [sense] and 5′ ctgtggagtgactaaatgg
aaacc-3′ [antisense] primers for β-actin DNA) were used.
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Real-time PCR conditions for the amplification process
were as follows: 95 °C (15 s); 40 cycles at 95 °C (15 s), and
60 °C (1 min). Samples without template controls were
used in each run. The ΔCt values were determined, where
Ct is the threshold cycle. For each cell line, the number of
human cells present in the murine organs (the degree of
chimerism) was calculated according to the standard
curve generated by mixing different concentrations of
human cells with a constant number of murine cells in a
linear manner.
Annexin V–phosphatidylserine binding assay
Human carcinoma cells were treated in RPMI/0.5 %
BSA medium containing either 1,25-dihydroxyvitamin
D3 (10−10 M, 10−9 M, or 10−8 M) or vehicle only. Cells
subjected to culture medium with 10 % DMSO were
used as a positive control. After a 12-h treatment period,
the cells were gently detached using non-enzymatic cell
dissociation buffer (Sigma-Aldrich), pelleted, and washed
twice with cold PBS. Next, to define the levels of early
and late apoptotic cells, the FITC Annexin V Apoptosis
Detection kit (#556547; BD Pharmingen) was employed
according to the manufacturer’s protocol. In brief, 1 ×
105 cells/100 μL Annexin V Binding Buffer were incu-
bated in the dark with FITC–annexin V and propidium
iodide (PI), as a vital dye, for 15 min at 25 °C. The cells
that were left unstained or stained with either FITC–
annexin V or PI served as compensation staining con-
trols. Afterwards, cells were analyzed by flow cytometry
after adding Annexin V Binding Buffer (400 μL) to all
tubes. The percentage of cells that had undergone
apoptosis was then determined by calculating the per-
centage of apoptotic cells in the untreated population
(vehicle) from the percentage of apoptotic cells in the
1,25-dihydroxyvitamin D3-treated population.
Data analysis
Statistical analysis was carried out using GraphPad Prism
6 (GraphPad Software Inc) and Sigma software (Sigma
Software Inc). All data are presented as mean ± SD. Statis-
tical analysis of the data was done using one-way ANOVA
and Tukey’s test for post hoc pairwise multiple compari-
son. In all analyses, p ≤ .05, p ≤ .01, and p ≤ .001 were
considered significant.
Results
Functional vitamin D3 receptor (VDR) is expressed in
established human and murine germline cell lines and in
very small embryonic-like stem cells (VSELs)
To address the role of vitamin D3 in germline-derived
cells, we first evaluated expression of the VDR receptor
in human and murine germline-derived cells and next
evaluated whether these receptors are functional by
studying the effect of vitamin D3 stimulation on phos-
phorylation of MAPKp42/44 and AKT kinases.
Figure 1a, b, left panels show that the human ovarian
cancer cell line (A2780) as well as the human (NTERA2)
and murine (P190) teratocarcinoma cell lines express
mRNA for the VDR. Importantly, we provide evidence
that stimulation by vitamin D3 induces phosphorylation
of MAPKp42/44 and AKTser473 in these cells (Fig. 1a, b,
right panels). Next, we isolated mRNA from human and
murine VSELs and the corresponding hematopoietic stem
cells (HSCs) and detected expression of VDR mRNA in all
these cells. As expected, the VDR was also expressed in
peripheral blood mononuclear cells (MNCs, Fig. 1c, left
and right panels).
To address whether VSELs respond to stimulation by
vitamin D3, we applied it for a prolonged period of time
in mice to evaluate the incorporation of bromodeoxyuri-
dine (BrdU) into VSELs and HSCs. We found that, while
~30 % of murine HSCs from vitamin D3-treated mice
were BrdU+ regardless of whether they were injected
with vitamin D3, the number of quiescent BrdU+ VSELs
increased from ~7 % to ~14 % in mice injected with
vitamin D3 (Additional file 2: Figure S2).
This result supports the conclusion that functional
VDRs are expressed on primitive human and murine
germline-derived tumor cells as well as on normal VSELs.
Vitamin D3 inhibits spontaneous migration, adhesion,
and proliferation of germline-derived tumor cells
Based on observations from the literature that vitamin
D3 has anti-metastatic properties [23, 24], we evaluated
spontaneous migration of human and murine germline-
derived tumor cells in response to vitamin D3 and ob-
served a dose-dependent decrease in their spontaneous
migration (Fig. 2, panel a) as well as adhesion to fibro-
nectin (Fig. 2, panel b).
These changes in migration and adhesion can be ex-
plained by the pro-apoptotic effects of increasing doses
of vitamin D3 (Fig. 3). As shown in Fig. 3, panel a,
exposure of the A2780 ovarian cancer cell line to vita-
min D3 resulted in an increase in the number of early
and late apoptotic cells, which correlated with impaired
vitamin D3 signaling in these cells (Fig. 3, panel b).
In parallel, these apoptotic changes corresponded with
an inhibitory effect of vitamin D3 on proliferation of
human and murine germline-derived malignant cell lines
(Fig. 4).
Exposure of germline-derived malignant cells to vitamin
D3 inhibits their seeding efficiency after injection into
immunodeficient mice
Next, to assess the effect of vitamin D3 on the meta-
static potential of germ line-derived tumor cells in vivo,
we exposed A2780 human ovarian cancer (Fig. 5, panel a)
Abdelbaset-Ismail et al. Journal of Ovarian Research  (2016) 9:26 Page 5 of 12
AB
C
Fig. 1 Human and murine germline-derived immortalized cell lines and FACS-sorted very small embryonic-like stem cells (VSELs) and hematopoietic
stem cells (HSCs) express functional vitamin D receptors (VDRs). Expression of VDRs was detected in purified mRNA samples from human teratocarcinoma
(hNTERA2) and ovarian cancer (hA2780) cell lines (Panel a, left) as well as from the murine embryonal teratocarcinoma (mP19) cell line (Panel b, left) by
both real-time and conventional reverse transcription polymerase chain reaction (RT-PCR). The effect of 1,25-dihydroxyvitamin D3 on phosphorylation of
p42/44 MAPK and AKTser473 intracellular pathway proteins in hNTERA2 and hA2780 cell lines (Panel a, right) and the mP19 cell line (Panel b, right) was
investigated. Cells (2 × 106 cells/mL) were starved for 12 h in their respective basic culture media containing 0.5 % BSA and stimulated afterwards for
5 min with 1,25-dihydroxyvitamin D3 at various concentrations (10−10–10−8 M) or with vehicle (DMSO) only. The experiment was carried out twice with
similar results, and representative blots are shown. Panel c The VDR is expressed by sorted VSELs and HSCs. RT-PCR showed expression of the VDR by
both murine BM-derived (left panel) and human UCB-derived (right panel) VSELs, HSCs, and MNCs. In all experiments, samples with water only instead of
cDNA (−cDNA) and without reverse transcriptase (−RT) were used as negative controls. Representative agarose gels of the RT-PCR amplicons obtained
are shown. Each experiment was carried out twice with similar results, and representative blots are shown
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and NTERA2 human teratocarcinoma cells (Fig. 5,
panel b) to vitamin D3 before i.v. injection into immu-
nodeficient mice. Incubation of tumor cells before in-
jection with vitamin D3 decreased seeding efficiency of
these cells into bone marrow, liver, and lung. This
decrease in seeding efficiency can again be explained by
the combined pro-apoptotic (Fig. 3), anti-proliferative
(Fig. 4), anti-migratory (Fig. 2, panel a), and anti-adhesive
(Fig. 2, panel b) effects of vitamin D3.
The ESD3 murine embryonic stem cell line expresses
functional VDRs
Finally, to address how early in embryonic development
functional VDRs are expressed, we evaluated expression
of this receptor on cells from the ESD3 murine embryonic
cell line and observed that this receptor is expressed and
responds to stimulation by vitamin D3 by phosphorylation
of p42/44 MAPK and AKT (Additional file 3: Figure S3).
Interestingly, in contrast to malignant cells derived from
germline tumors, we found that vitamin D3 does not
inhibit migration of these cells.
Discussion
The salient observation of the current work is that func-
tional vitamin D3 receptors (VDRs) are expressed in a
broad range of normal and malignant cells whose origin
is related to the germline. In addition, it is known that
the VDR is not only expressed by ovarian and testicular
A
B
Fig. 2 Panel a 1,25-dihydroxyvitamin D3 inhibits migration of human and murine germline-derived cell lines. Transmigration of a human ovarian
cancer cell line (A2780), a human teratocarcinoma cell line (NTERA-2), and a murine embryonal teratocarcinoma cell line (P19) through Transwell
membranes (8-μm pore size) in response to 1,25-dihydroxyvitamin D3 at the indicated concentrations. Cells were rendered quiescent in 0.5 % BSA in
culture medium overnight at 37 °C. The effects of 1,25-dihydroxyvitamin D3 on migration of all cell lines employed (6 × 104 cells/100 μL/insert) were
also evaluated in parallel for migration in response to 10 % FBS and 0.5 % BSA plus vehicle as a positive and negative control, respectively.
Twenty-four hours later, the migrated cells were stained and counted using an inverted microscope. Panel b 1,25-dihydroxyvitamin D3 interferes with
the adhesiveness of human and murine germline-derived cell lines to fibronectin. Adhesion of the A2780 human ovarian cancer cell line, the NTERA-2
human teratocarcinoma cell line, and the P19 murine embryonal teratocarcinoma cell line to fibronectin-coated surfaces in response to
1,25-dihydroxyvitamin D3. After three hours of quiescence, cells (3000 cells/100 μL) were stimulated with 1,25-dihydroxyvitamin D3 at the
indicated concentrations in medium with 0.5 % BSA for 5 min at 37 °C. After the non-adherent cells were removed by three consecutive
washes with PBS, the number of adherent cells was measured by microscopic analysis. The effects of 1,25-dihydroxyvitamin D3 on adhesion of all cell
lines employed were also evaluated for adhesion compared with stromal-derived factor 1 (300 ng/mL) and culture medium containing 0.5 % BSA plus
vehicle as a positive and negative control, respectively. The negative control values are normalized to 100 %. Data are displayed as means ± SD, with a
statistical significance *p≤ 0.05 versus control (unstimulated) cells
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cancer cells [22, 28] but is also expressed on murine
and human teratocarcinoma cells, murine embryonic
stem cells, and developmentally early stem cells that
express several primordial germ cell markers isolated
from adult tissues, which have been described as very
small embryonic-like stem cells (VSELs) [5–7, 31].
Vitamin D3 plays an important role in several physio-
logical and pathological processes [26, 33]. It ameliorates
hypertension, prevents osteoporosis, shows anti-diabetic
effects, and plays an important role in embryonic devel-
opment, including gametogenesis [34–38]. In the female
reproductive system, vitamin D3 is involved in several
stages of folliculogenesis, as it is essential in cell prolifer-
ation, cell differentiation, and estrogen biosynthesis [39].
These positive effects are partially explained by attenu-
ation of the negative effects of TGF-β1 on gametogenesis
[38]. The role of vitamin D3 is also well documented in
the male reproduction system. Specifically, mutant VDR-
null mice develop reduced fertility later in life, which
implies that the effect of vitamin D3 is exerted directly on
the germ cells and/or indirectly by modulating Leydig cell
function [38].
Evidence has accumulated from epidemiological stud-
ies that vitamin D3 and exposure to solar ultraviolet
radiation have inverse relationships with non-skin cancer
mortality. Specifically, sunlight protects against ovarian,
breast, prostate, and colon cancer [40]. On the other
hand, vitamin D3 deficiency enhances the risk of several
malignancies, including gonadal tumors [41]. Consistent
with this effect, multiple ovarian and testicular cancer
cell lines respond to stimulation by vitamin D3 by growth
suppression and induction of apoptosis [22], and the
antiproliferative effect of this prohormone is mediated
by increasing p27 protein stability and up-regulation
of GADD45 [42, 43]. On the other hand, induction of
apoptosis in ovarian cancer cell lines has been ex-
plained by downregulation of mRNA stability of the
telomerase catalytic subunit [44]. Vitamin D3 or its
analogs have been demonstrated to inhibit the growth
of ovarian cancer tumors in in vivo xenograft animal
A
B
Fig. 3 1,25-dihydroxyvitamin D3 induces apoptosis of human ovarian cancer cells in vitro. Panel a The A2780 human ovarian cancer cell line was
treated with 1,25-dihydroxyvitamin D3 at concentrations ranging from 10−10–10−8 M for 16 h, and apoptosis was detected using the AnnexinV–FITC
apoptosis kit and analyzed using flow cytometry. The data shown here indicate the induction of significant early apoptosis in cells treated with 10−9 M
1,25-dihydroxyvitamin D3 compared with cells treated with vehicle only. In this experiment, 10 % DMSO was used as positive control. The means of
two experiments in triplicate were used. For statistical comparisons, a one-way analysis of variance and a Tukey’s test for post hoc analysis were carried
out, and means ± SD are shown. Significance level: *p≤ 0.05 versus control (untreated) cells. Panel b In parallel, treatment of the A2780 human ovarian
cancer cell line with 1,25-dihydroxyvitamin D3 led to inhibition of phosphorylation of the p42/44 MAPK and AKTser473 intracellular pathway proteins in
dose-dependent responses. Human ovarian cancer cells (2 × 106 cells/mL) were incubated for 12 h in RPMI with 0.5 % BSA culture medium containing
either 1,25-dihydroxyvitamin D3 at various concentrations (10−10–10−8 M) or vehicle only. The experiment was carried out twice with similar results,
and representative blots are shown
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models and inhibit angiogenesis in those malignancies
[23]. Vitamin D3 has also been demonstrated to show
synergistic anti-tumor effects in combination with cy-
tostatics such as carboplatin [45]. Interestingly vita-
min D3 has been reported to inhibit leptin-mediated
cancer growth by upregulating miR-498, which down-
regulates leptin-enhanced expression of mRNA encoding
telomerase reverse transcriptase (hTERT) [46]. Finally,
decreased expression of CYP27B1, which hydroxylates
25-hydroxyvitamin D3 into biologically active 1,25-dihy-
droxyvitamin D3 (calcitriol) correlates with the increased
pro-metastatic potential of ovarian cancer cells [21].
In our work we have shown that, like other ovarian
cancer cell lines, human A2780 expresses functional VDRs
and that its growth is inhibited by vitamin D3 in a dose-
dependent manner. We observed a parallel effect on the
viability of these cells. Moreover, we present new results
that ovarian cancer cells exposed to vitamin D3 show
impaired seeding efficiency in vivo to BM, liver, and lung
after intravenous injection into immunodeficient mice.
Importantly, in addition to a negative effect on ovarian
cancer cell growth, we report here that vitamin D3 also
inhibits proliferation of human and murine teratocarcin-
oma cell lines. In similar sets of experiments, we found
that these cells express functional VDRs and that vita-
min D3 inhibits their growth in vitro and ameliorates
metastatic potential in vivo after injection into immuno-
deficient mice. Functional VDRs were also found to be
expressed by murine immortalized embryonic stem cells.
Thus, expression of VDRs on these cells suggests why
the developing embryo is susceptible to changes in
vitamin D3 exposure [47].
Interestingly, in contrast to established germline-derived
cell lines, we found that vitamin D3 stimulates prolifera-
tion of normal developmentally early stem cells residing in
adult tissues (VSELs). We observed that prolonged ad-
ministration of vitamin D3 to mice resulted in an increase
in BrdU incorporation into these otherwise very quiescent
cells residing in bone marrow (BM) [48]. This is interest-
ing for several reasons. First, VSELs have been reported to
be at the top of the mesenchymal lineage hierarchy and
are thus precursors for mesenchymal stem cells [49, 50].
Based on our results, the increase in the number of
VSELs may at least partially explain the beneficial effect
A B
C
Fig. 4 1,25-dihydroxyvitamin D3 suppresses proliferation of human and murine germline-derived cell lines. Proliferation of the A2780 human ovarian
cancer cell line (Panel a) as well as the NTERA-2 human teratocarcinoma (Panel b) and mP19 murine embryonal teratocarcinoma (Panel c) cell lines
was significantly decreased by 1,25-dihydroxyvitamin D3 in a dose-dependent manner in comparison with cells treated with vehicle only.
All proliferation experiments were done either in RPMI (for A2780), DMEM (for NTERA-2), or αMEM (for P19) culture medium containing
0.5 % BSA for 72 h using 0.3 × 104 cells/well in a 96-well plate. The negative control values are normalized to 100 %. For each cell line,
the experiment was repeated twice in triplicate with similar results
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of vitamin D3 supplementation on bone growth and in
ameliorating or preventing osteoporosis [35]. It is most
likely that, by giving rise to mesenchymal stem cells,
VSELs supply new osteoblasts, cartilage cells, and stro-
mal cells.
It has also been reported in several elegant papers that
VSEL-like cells reside in adult ovaries and testes [51, 52].
In parallel, it has been proposed that gonadal VSELs could
be the precursors of gametes [53–55]. Thus, it is possible
that some of the abovementioned beneficial effects of
vitamin D3 on the reproductive system can be explained
by the direct effect of vitamin D3 on the gonadal popula-
tion of VSELs.
The expression of VDRs in germline-derived cells as
well as VSELs provides additional support for a devel-
opmental relationship between these cells [49]. We
have already demonstrated that VSELs express several
markers of migrating primordial germ cells [7]. Moreover,
our recent work demonstrated expression of functional
erythropoietin receptors on germline-derived cells, includ-
ing ovarian cancer and teratocarcinoma cells and VSELs
[56]. Expression of functional VDRs again supports a
potential developmental relationship between these cells.
In conclusion, our report shows that the VDR is
expressed across a spectrum of germline-derived tumors,
from teratocarcinoma cells to ovarian cancer cells, and
supports our proposal that vitamin D3 is an inhibitor of
their proliferation. We also provide new evidence that
normal germline-related stem cells (VSELs) can prolifer-
ate in vivo after administration of vitamin D3. This dual
(and opposing) role of vitamin D3 on proliferation of
normal germline-derived cells and inhibition of malig-
nant germline tumor growth explains better some bene-
ficial effects of vitamin D3 supplementation in normal
as well as in pathological processes.
Conclusions
Based on this data vitamin D3 supplementation is im-
portant for normal development and embryogenesis as it
promotes growth of normal development early stem cells,
and on other hand we provide further justification to em-
ploy vitamin D3 in the clinic as an anticancer compound
to inhibit tumor expansion.
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Additional files
Additional file 1: Figure S1. The list and sequences of the primer pairs
used in this study. (PPT 142 kb)
Additional file 2: Figure S2. 1,25-dihydroxyvitamin D3 induces
proliferation of quiescent BM-derived very small embryonic-like stem
cells (VSELs) in vivo. Panel A. After treatment with 1,25-dihydroxyvitamin D3,
as shown here, no significant difference in BrdU-incorporated HSCs was
observed in treated and control animals (6 male mice/group). Panel B.
BrdU incorporation into VSELs after 1,25-dihydroxyvitamin D3 treatment.
The percentages of VSELs that incorporated BrdU into newly synthesized
DNA. After treatment with 1,25-dihydroxyvitamin D3 at 800 IU/dose,
~13.2 % of VSELs were BrdU+, in contrast to the control group in which
~7 % of VSELs were BrdU+ (6 male mice/group). The incorporation of BrdU
into HSCs and VSELs was measured by FACS. (PPT 100 kb)
Additional file 3: Figure S3. ESD3 murine embryonic stem cells
express functional VDRs. Expression of VDRs was detected in purified
mRNA samples from the ESD3 cell line as well as in murine BM-derived
HSCs and MNCs (Panel A) by conventional reverse transcription polymerase
chain reaction (RT-PCR). Samples with water only instead of cDNA (−cDNA)
and without reverse transcriptase (−RT) were used as negative controls.
Representative agarose gels of the RT-PCR amplicons obtained are shown.
The effect of 1,25-dihydroxyvitamin D3 on phosphorylation of p42/44 MAPK
A
B
Fig. 5 1,25-dihydroxyvitamin D3 inhibits metastasis of human ovarian
cancer and teratocarcinoma cells. Detection of in vivo-transplanted
1,25-dihydroxyvitamin D3-treated A2780 human ovarian cancer cells
(a) and hNTERA-2 human teratocarcinoma cells (b) in the organs of
irradiated mice post transplantation. As shown, the number of 1,25-
dihydroxyvitamin D3-treated cancer cells was significantly lower in
isolated organs from mice than in ex vivo-untreated cells (vehicle only).
Detection was performed by employing RT-qPCR for the presence of
human Alu sequences in purified genomic DNA samples. For statistical
comparisons, a one-way analysis of variance and a Tukey’s test for post
hoc analysis were carried out, and means ± SD are shown. Significance
levels: *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001 versus control (untreated) cells
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and AKTser473 intracellular pathway proteins in ESD3 cells (Panel B) was
assessed. Cells (106 cells/mL) were starved for 12 h in their respective culture
media containing 0.5 % BSA in an incubator and afterwards stimulated for
5 min with 1,25-dihydroxyvitamin D3 at various concentrations (0.1–100 nM)
or with vehicle (DMSO) only. The experiment was carried out twice with
similar results, and representative blots are shown. Panel C. Vitamin D3 does
not inhibit Transwell migration of murine ESD3 cells. The experiment was
performed twice with similar results. (PPT 293 kb)
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